U.S. Biotech Stock News

Central Pacific Financial (CPF) opened Q2 2026 with total revenue of US$73.1 million and basic EPS of US$0.80, backed by trailing twelve month revenue of US$288.2 million and EPS of US$3.13 that sit on top of 36.8% earnings growth over the last year. The company has seen revenue move from US$247.7 million to US$288.2 million over the trailing twelve months, while net income over that span went from US$58.2 million to US$83.0 million, setting up this quarter’s print against an improved net...

Jazz Pharmaceuticals has delivered a strong share price run over the past year, yet its current valuation checks still flag a mixed picture rather than a clear bargain or clear overvaluation. Jazz Pharmaceuticals has returned 114.7% over the past year, which places extra focus on whether recent optimism is already reflected in the price. Ongoing interest in Jazz Pharmaceuticals' revenue growth and product pipeline can support confidence in future cash flows, while any setback in key...

Ovintiv (OVV) is back in focus after a busy second quarter, with revenue of US$3.01b, updated production guidance and a mix of shareholder returns through dividends and buybacks. See our latest analysis for Ovintiv. Ovintiv’s recent Q2 revenue beat, updated production guidance, dividend declaration and active buybacks come against a strong backdrop, with a 30 day share price return of 18.69% and a 1 year total shareholder return of 56.29%, suggesting momentum has been building rather than...

Lamb Weston Holdings (LW) has released its FY 2026 numbers with Q4 revenue of US$1,770.1 million and basic EPS of US$0.80, alongside trailing 12 month revenue of US$6.6 billion and basic EPS of US$2.09. This provides a clear snapshot of current scale and earnings power. The company has seen revenue move from US$6.4 billion in the trailing period to Q4 2026’s quarterly run rate, with EPS ranging between US$0.39 and US$0.85 a quarter over the last six reported quarters. This gives investors a...

Peloton Interactive (PTON) is back in focus after fresh attention on its connected fitness model, which spans hardware, app memberships, and equipment leasing across North America and international markets. See our latest analysis for Peloton Interactive. Peloton Interactive’s recent 30 day share price return of 6.29% and 90 day share price return of 14.50% contrast with a 1 year total shareholder return that declined 7.32%, suggesting near term momentum while longer term holders have faced...

Chord Energy stock has delivered strong total returns over the past five years, yet current valuation checks suggest the shares no longer stand out as obviously cheap. Instead, they look closer to fairly priced on most measures. Over the past five years, Chord Energy has returned 133.6%, which puts current holders in a comfortable position and raises the bar for new buyers assessing what is already priced in. Expectations around Chord Energy potentially beating upcoming earnings estimates...

Persistent grocery inflation, shoppers trading down to cheaper options, and price rollbacks at major chains are shaking up discount retailers. Some companies face squeezed margins, while others could benefit as customers hunt more aggressively for value. This article looks at how that tug of war might affect stocks exposed to the latest grocery price trends, and what that could mean for your watchlist. Below, 3 stocks from a Discount Retailers screener, all potentially positively exposed to...

Universal (UVV) has drawn fresh investor attention after recent trading left the stock at a last close of US$53.75. This invites a closer look at how its value and fundamentals currently line up. See our latest analysis for Universal. Recent trading has been relatively steady, with a 1-day share price return of 1.97% and a year-to-date share price return of 2.23%. The 5-year total shareholder return of 39.88% points to momentum that has built over a longer period. If Universal has you looking...

The Trump administration’s decision to make tariffs permanent on 99.4% of U.S. imports and introduce new 10% to 12.5% rates on goods from 60 countries could reshape where risks and opportunities sit in your portfolio. For investors who prefer smaller U.S. stocks with value traits, this backdrop may put more attention on companies that are priced modestly, pay dividends, and are less tied to global supply chains. This article looks at 3 small-cap value stocks from our screener that appear...

Diamondback Energy has delivered a powerful run over the last five years, yet the valuation checks now suggest the stock looks closer to fairly priced than clearly cheap. Diamondback Energy has returned 228.0% over five years, which puts more pressure on today’s buyers to judge whether that kind of performance already reflects much of the good news. Expectations for strong production and cash generation from core Permian Basin assets can support the current share price. However, any setback...

Corcept Therapeutics (CORT) is back in focus after the FDA approved Lifyorli, its relacorilant combination for platinum resistant ovarian cancer. This development broadens revenue sources beyond flagship drug Korlym. See our latest analysis for Corcept Therapeutics. Corcept Therapeutics has seen strong share price momentum, with a 30 day share price return of 16.92% and a 90 day share price return of 107.03%. The 1 year total shareholder return of 39.64% and 5 year total shareholder return of...

Earlier this week, Cabot Corporation received an upgrade from Zacks to a Rank #2 (Buy), reflecting increased optimism around its earnings outlook and improved estimate revisions. This shift in analyst sentiment suggests that Cabot's underlying business trends are being viewed more favorably, potentially reinforcing confidence in its longer-term earnings profile. Next, we’ll examine how this improved earnings outlook, as flagged by the Zacks upgrade, interacts with Cabot’s existing investment...

Earlier this week, UiPath came under pressure after OpenAI released its Presence AI agent deployment platform, raising worries about intensified competition in enterprise automation. The comparison has highlighted how UiPath’s Maestro platform differs by coordinating both AI agents and software bots while remaining model-agnostic, which may matter more than headline competition alone. Next, we’ll explore how concerns around OpenAI Presence’s competitive threat could influence UiPath’s...

Lattice Semiconductor (LSCC) is back in focus after reporting better than expected results and issuing stronger guidance, alongside a planned $1b acquisition of AMI to expand its data center and firmware capabilities. See our latest analysis for Lattice Semiconductor. Lattice Semiconductor’s latest guidance and the planned AMI acquisition come after a sharp pullback, with the share price down 7.03% on the day and 10.78% over 30 days. This comes alongside a 63.28% year to date share price...

SLB stock has more than doubled over the past five years, and the latest Discounted Cash Flow (DCF) work still points to an intrinsic value comfortably above the current share price, even as broader valuation checks come through with a more mixed message. SLB has returned 102.9% over the last five years, so current holders are sitting on sizeable gains that put more focus on whether the share price still lines up with fundamentals. Growth potential from subsea contracts and AI focused data...

Patterson-UTI Energy, Inc. recently prepared to report its second-quarter 2026 results, with consensus pointing to a 3 cents per share loss on expected revenues of US$1.15 billion amid pressure across its Drilling Services, Completion Services, and Drilling Products segments and higher operating costs. At the same time, the company’s longer-term profile of annual revenue growth, large US$4.66 billion scale, and improving EBITDA efficiency has kept attention on how its cost structure and...

AMETEK stock has delivered a strong 79.8% return over the past five years, yet current valuation checks, including an intrinsic value estimate based on a Discounted Cash Flow (DCF) model and market multiples, both point to the shares trading at a premium rather than offering clear value. The 79.8% five year return highlights that long term holders have already captured a substantial gain. This can reduce the margin of safety for new investors if fundamentals do not keep pace. Expectations...

Twist Bioscience stock has delivered a very strong 261.2% return over the past 3 years, yet the broader valuation checks point to a company that currently appears expensive rather than obviously cheap. That tension between a powerful share price run and a low value score is what investors now have to weigh. Twist Bioscience's 261.2% return over 3 years highlights how much optimism is already reflected in the share price. Expectations around the company turning its science into durable...

With the average 30 year mortgage rate at 6.58% and the 10 year Treasury yield at 4.7%, banks and mortgage lenders are sitting at the center of some powerful cross currents in borrowing costs, inflation expectations and housing activity. Higher rates can reshape profit pools, squeeze some business lines and open opportunities in others. This article breaks down how that rate backdrop and the recent conflict driven move in oil prices tie into the Financial Sector, Banks and Mortgage Lenders...

Delays at the Rosebank oilfield, now expected to push first production to at least 2027, have put a spotlight on stocks tied to North Sea projects. When equipment is stuck on the seabed and rigs are idle for months, project cash flows and investor expectations can quickly shift. This article looks at how that kind of disruption, along with uncertain UK government decisions on future North Sea drilling, may pressure companies closely linked to offshore development. It will walk through 3...

In the second quarter of 2026, Chubb Limited reported earnings above analyst estimates, supported by higher underwriting and investment income, modest consolidated net premium written growth of 3.6% across its Property & Casualty and Life Insurance segments, and the completion of a multi-year US$4.45 billion share repurchase program totaling 14,811,112 shares. At the same time, Chubb reshaped leadership at its global reinsurance arm, Chubb Tempest Re, naming long-time industry veteran James...

With investors watching inflation, energy prices, and interest-rate decisions across major economies, companies linked to aerospace and defense sit at the crossroads of government spending, security demand, and complex global supply chains. The Aerospace And Defense stock screener filters this universe down to businesses that are directly connected to aircraft, space, and defense equipment or services, helping you cut through a crowded sector. In this article you will see 3 stocks from this...

Election rules are back in the headlines after a federal appeals court blocked President Trump’s executive order on mail in voting, and that legal back and forth is feeding into expectations for media and advertising activity around November. For investors, the key question is how this legal pause and the preserved status quo for mail in voting might influence companies that rely on election season attention and spending. This article breaks down 3 stocks from our Media and Advertising Stocks...

Autodesk recently joined the Alliance for OpenUSD, backing efforts to secure ISO certification for the OpenUSD Core Specification 1.1 and promote a unified 3D data layer across gaming, extended reality, and enterprise workflows. This move ties Autodesk’s tools more closely to an emerging standard for interoperable 3D content and agentic AI workflows, potentially deepening its relevance across design-intensive industries. We’ll now examine how Autodesk’s deeper commitment to OpenUSD-based...